SK65197A3 - Lubeluzole intravenous solutions - Google Patents

Lubeluzole intravenous solutions Download PDF

Info

Publication number
SK65197A3
SK65197A3 SK651-97A SK65197A SK65197A3 SK 65197 A3 SK65197 A3 SK 65197A3 SK 65197 A SK65197 A SK 65197A SK 65197 A3 SK65197 A3 SK 65197A3
Authority
SK
Slovakia
Prior art keywords
lubeluzole
solution
addition salt
water
pharmaceutically acceptable
Prior art date
Application number
SK651-97A
Other languages
English (en)
Slovak (sk)
Inventor
Marc K J Francois
Jozef Peeters
Christiane G G M Heyns
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SK65197A3 publication Critical patent/SK65197A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK651-97A 1994-11-24 1995-11-16 Lubeluzole intravenous solutions SK65197A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203422 1994-11-24
PCT/EP1995/004520 WO1996015790A1 (en) 1994-11-24 1995-11-16 Lubeluzole intravenous solutions

Publications (1)

Publication Number Publication Date
SK65197A3 true SK65197A3 (en) 1997-12-10

Family

ID=8217408

Family Applications (1)

Application Number Title Priority Date Filing Date
SK651-97A SK65197A3 (en) 1994-11-24 1995-11-16 Lubeluzole intravenous solutions

Country Status (19)

Country Link
US (1) US5744484A (fi)
EP (1) EP0794777A1 (fi)
JP (1) JPH10509712A (fi)
CN (1) CN1166787A (fi)
AR (1) AR002001A1 (fi)
AU (1) AU693969B2 (fi)
BR (1) BR9509821A (fi)
CA (1) CA2205606A1 (fi)
CZ (1) CZ155897A3 (fi)
FI (1) FI972204A (fi)
HU (1) HUT77390A (fi)
IL (1) IL116102A (fi)
MX (1) MX9703839A (fi)
NO (1) NO972303D0 (fi)
PL (1) PL320296A1 (fi)
SK (1) SK65197A3 (fi)
TR (1) TR199501482A1 (fi)
WO (1) WO1996015790A1 (fi)
ZA (1) ZA959995B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AU7298196A (en) * 1995-10-25 1997-05-15 Janssen Pharmaceutica N.V. Infusions of neuroprotectants and perfluorochemicals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010198A (en) * 1984-12-03 1991-04-23 Janssen Pharmaceutica N.V. Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
HUT77390A (hu) 1998-04-28
IL116102A (en) 2000-02-29
FI972204A0 (fi) 1997-05-23
ZA959995B (en) 1997-05-23
WO1996015790A1 (en) 1996-05-30
CZ155897A3 (en) 1997-10-15
MX9703839A (es) 1997-08-30
BR9509821A (pt) 1997-10-21
US5744484A (en) 1998-04-28
NO972303L (no) 1997-05-21
FI972204A (fi) 1997-05-23
IL116102A0 (en) 1996-01-31
PL320296A1 (en) 1997-09-15
AR002001A1 (es) 1998-01-07
CN1166787A (zh) 1997-12-03
AU4172996A (en) 1996-06-17
JPH10509712A (ja) 1998-09-22
EP0794777A1 (en) 1997-09-17
NO972303D0 (no) 1997-05-21
AU693969B2 (en) 1998-07-09
CA2205606A1 (en) 1996-05-30
TR199501482A1 (tr) 1996-10-21

Similar Documents

Publication Publication Date Title
EP1501496B1 (en) Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
NZ522324A (en) Stabilized aqueous suspensions for parenteral use
AU2001267371A1 (en) Stabilized aqueous suspensions for parenteral use
CN103079559A (zh) 包含胺碘酮及其盐的制剂及其制造和使用方法
EP1396268B1 (en) Stable oxazaphosphorine-2-mercaptoethanesulphonate formulations
US20100249413A1 (en) Stabilized pharmaceutical composition
SK65197A3 (en) Lubeluzole intravenous solutions
US8293749B2 (en) Injectable meclizine formulations and methods
JP2007519702A (ja) ニューロキニン受容体拮抗薬及びシクロデキストリンからなる医薬組成物、ならびに注射部位の耐容性を改善するための方法
JP2022529047A (ja) 安定かつ保存されているビラスチンの医薬組成物
EP1864664A1 (en) Pharmaceutical preparation
RU2804366C2 (ru) Состав ингибитора bcl-2 на основе циклодекстрина
US20040072797A1 (en) Storage stable eplerenone formulation
AU2007293174A1 (en) Aqueous formulation comprising an antitumor agent
MXPA97003839A (en) Intravenous solutions of lubelu
EA044714B1 (ru) Состав ингибитора bcl-2 на основе циклодекстрина